In hepatocellular carcinoma (HCC), overexpression of MYC is closely related to cell cycle progression and apoptosis, and inhibition of MYC can significantly improve the sensitivity of HCC cells to chemotherapy (Papadopoulos et al., 2023). Here, MYC is linked to hepatocellular carcinoma.